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Table S1. Baseline characteristics by blood pressure group at ages 20-34 years Table S2 . Baseline characteristics by blood pressure group at ages 35-49 years Table S3 . Baseline characteristics by blood pressure group at ages 50-64 years Table S4 . Baseline characteristics by blood pressure group at ages 65-79 years Table S5 . Baseline characteristics by blood pressure group at ages 80-94 years Table S6 . Age-specific CVD risks according to blood pressure group with or without competing risk analysis Figure S1. Flowchart of inclusion and exclusion criteria Figure S2 . Age-specific mortality rate according to blood pressure group Figure S3 . Sex-and age-specific CVD incidence and mortality rates according to blood pressure group Figure S4 . Sex-and age-specific CVD and mortality risks according to blood pressure group among persons not taking antihypertensive medication Figure S5 . Age-specific CVD and mortality risks according to blood pressure group among persons who have not started antihypertensive medication up to one year of follow-up Figure S6 . Age-specific CVD and mortality risks according to blood pressure group with stage 2 hypertension defined as SBP ≥140 mmHg or DBP ≥90 mmHg or treated Figure S7 . Age-specific CVD and mortality risks according to blood pressure group with or without antihypertensive medication Figure S8 . Age-specific CVD and mortality risks according to blood pressure group defined by measurements from two different examinations Mortality rate per 100,000 person−years Figure S3 . Sex-and age-specific CVD incidence and mortality rates according to blood pressure group. CVD, cardiovascular disease; HT, hypertension. Figure S5 . Age-specific CVD and mortality risks according to blood pressure group among persons who have not started antihypertensive medications up to one year of follow-up. Rates per 100,000 person-years. HRs adjusted for age, sex, household income, Charlson Comorbidity Index, use of glucose-lowering drugs, use of lipid-lowering drugs, smoking, drinking, exercise, body mass index, fasting glucose, and total cholesterol. BP, blood pressure; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; HT, hypertension. Figure S7 . Age-specific CVD and mortality risks according to blood pressure group with or without antihypertensive medication. Rates per 100,000 person-years. HRs adjusted for age, sex, household income, Charlson Comorbidity Index, use of glucose-lowering drugs, use of lipid-lowering drugs, smoking, drinking, exercise, body mass index, fasting glucose, and total cholesterol. BP, blood pressure; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; HT, hypertension. Figure S8 . Age-specific CVD and mortality risks according to blood pressure group defined by measurements from two different examinations. Rates per 100,000 person-years. HRs adjusted for age, sex, household income, Charlson Comorbidity Index, use of glucoselowering drugs, use of lipid-lowering drugs, smoking, drinking, exercise, body mass index, fasting glucose, and total cholesterol. BP, blood pressure; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; HT, hypertension. 
